Evidence map›Paper›PMID 40197966›Full record

ArticleRevista do Instituto de Medicina Tropical de Sao Paulo2025

Spatial epidemiologic trends of cutaneous leishmaniasis in Rio de Janeiro State, Southeast Brazil, 2001-2020.

Tayana Patrícia Santana Oliveira de Sá, Sandro Javier Bedoya-Pacheco, Rafael Ramalho Cunha-E-Silva, Alex de Oliveira Vasconcelos, Mônica de Avelar Figueiredo Mafra Magalhães, Cristina Maria Giordano Dias, Juliana Gonçalves Dos Reis, Liliane de Fátima Antonio Oliveira, Andreza Pain Marcelino, Maria Inês Fernandes Pimentel

Abstract read
In one paragraph

Article in Revista do Instituto de Medicina Tropical de Sao Paulo, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tayana Patrícia Santana Oliveira de SáFundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas, Laboratório de Pesquisa Clínica e Vigilância em Leishmanioses, Rio de Janeiro, Rio de Janeiro, Brazil.
Sandro Javier Bedoya-PachecoFundação Oswaldo Cruz, Escola Nacional de Saúde Pública Sérgio Arouca, Departamento de Epidemiologia e Métodos Quantitativos em Saúde, Rio de Janeiro, Rio de Janeiro, Brazil.ORCID http://orcid.org/0000-0003-1163-2268
Rafael Ramalho Cunha-E-SilvaFundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas, Laboratório de Pesquisa Clínica e Vigilância em Leishmanioses, Rio de Janeiro, Rio de Janeiro, Brazil.
Alex de Oliveira VasconcelosFundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas, Laboratório de Pesquisa Clínica e Vigilância em Leishmanioses, Rio de Janeiro, Rio de Janeiro, Brazil.
Mônica de Avelar Figueiredo Mafra MagalhãesFundação Oswaldo Cruz, Instituto de Comunicação e Informação Científica e Tecnológica em Saúde, Rio de Janeiro, Rio de Janeiro, Brazil.
Cristina Maria Giordano DiasSecretaria de Estado de Saúde do Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil.
Juliana Gonçalves Dos ReisFundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas, Laboratório de Pesquisa Clínica e Vigilância em Leishmanioses, Rio de Janeiro, Rio de Janeiro, Brazil.ORCID http://orcid.org/0000-0002-0847-4222
Liliane de Fátima Antonio OliveiraFundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas, Laboratório de Pesquisa Clínica e Vigilância em Leishmanioses, Rio de Janeiro, Rio de Janeiro, Brazil.
Andreza Pain MarcelinoFundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas, Laboratório de Pesquisa Clínica e Vigilância em Leishmanioses, Rio de Janeiro, Rio de Janeiro, Brazil.ORCID http://orcid.org/0000-0002-7197-2128
Maria Inês Fernandes PimentelFundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas, Laboratório de Pesquisa Clínica e Vigilância em Leishmanioses, Rio de Janeiro, Rio de Janeiro, Brazil.ORCID http://orcid.org/0000-0002-8159-0502

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cutaneous leishmaniasis (CL) has substantial epidemiological and clinical differences depending on host characteristics, Leishmania species and geographic areas. CL in Rio de Janeiro State was evaluated. Mandatory notifications of confirmed cases from 2001-2020 were analyzed considering sociodemographic and clinical variables, temporal trends, the Cutaneous Leishmaniasis Composite Indicator (CLCI) for each affected city in relation to the total of affected cities in the state, and each triennium from the beginning to the end of the time series (2001-2003, 2002-2004 until 2018-2020, sequentially). The number of cases decreased over time. High average incidence rates occurred in contiguous cities from the Southernmost to the Northernmost regions of Rio de Janeiro State, following areas where the Atlantic Forest persists. The CLCI showed temporal variations in the intensity of the risk of CL in the affected cities. Rio de Janeiro city was the only one with intense or very intense risk of CL throughout the studied period. The disease predominantly affected people residing in urban areas and in the middle age groups (20-59 years). CL also predominated in males, regardless of age. The mucosal clinical form was also significantly associated with men, with an 80% chance of them being more affected than women. Regarding diagnostic tests, the Leishmanin Skin Test showed higher positivity than the direct parasitological exam and the histopathological exam. No differences regarding cure between sexes were found. This study may guide control actions in areas where they are most needed in Rio de Janeiro State.

Indexed as

Leishmaniasis, CutaneousAdolescentAdultAgedAge DistributionBrazilChildChild, PreschoolFemaleHumansIncidenceInfantMaleMiddle AgedSocioeconomic FactorsYoung Adult

Identifiers

PMID40197966
PMCPMC11981078

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.